QSE and Baladna announce successful completion of Baladna’s capital increase and listing of new shares
Tribune News Network DohaQatar Stock Exchange and Baladna, Qatar’s largest dairy and beverage producer, announced today the successful completion of Baladna’s capital increase thro...
Qatar Stock Exchange (QSE) and Baladna, the nation's leading dairy and beverage producer, have announced the successful completion of Baladna's capital increase through a rights issue. The newly issued shares were listed and began trading on QSE. The company offered 535,996,240 new shares to existing shareholders on a one-for-four basis, with each share priced at QR1.01.
The subscription period closed on August 17, 2026. By the start of the trading session on August 18, 2026, all 120,507,405 unsubscribed shares had been sold, resulting in full coverage of the new shares offered. As a result, Baladna's issued and paid-up share capital increased from QR2,143,984,962 to QR2,679,981,202, marking a 25% rise.
This capital increase positions Baladna to accelerate its expansion plans, enhance production capacity, and strengthen its presence in regional and international markets. Baladna Chairman Moutaz Al Khayyat expressed his gratitude to shareholders for their support and acknowledged the collaboration of Qatar Stock Exchange, the Qatar Financial Markets Authority, and Edaa in making the transaction smooth and professional.
Qatar Stock Exchange CEO Abdulla Mohammed Al Ansari highlighted the significance of the transaction in enabling companies to access the capital markets and supporting market development. The successful execution of this transaction underscores QSE's commitment to providing companies with financing solutions to support their growth and Qatar's economic development objectives.
Written by urgent.news from Qatar Tribune Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Al Meera transfers 85.76 mn Baladna shares to investment portfolio qatar-tribune.com